{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:17:49Z","timestamp":1789078669436,"version":"build-2803163510"},"reference-count":24,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"published-print":{"date-parts":[[1995,5]]},"abstract":"<jats:p>Eleven newborns admitted consecutively to the neonatal unit with respiratory failure and severe persistent pulmonary hypertension (PPHN) were included in a clinical trial to assess the efficacy of magnesium sulphate (MgSO4) in the treatment of PPHN. A loading dose of 200 mg\/kg MgSO4 was given over 20 minutes, followed by a continuous infusion of 20-150 mg\/kg\/hour to obtain a magnesium blood concentration between 3.5 and 5.5 mmol\/l. Mean (SD) duration of treatment was 75.5 (19.8) hours. No other vasodilatory drug was administered before or during the treatment and patients were not hyperventilated. Mean (SEM) PaO2 values significantly increased from 42.6 (8.8) before treatment to 70.3 (24.1) mm Hg after 24 hours, with no change in pH or PCO2. Oxygen index and alveolar-arterial oxygen gradient (A-aDO2) were significantly lower after 24 hours; respectively, 46.8 (15.2) to 28.0 (9.0) and 624.3 (11.3) to 590 (58) mm Hg. Mean airway pressure could be significantly reduced from 19.5 (3.1) to 13.9 (3.9) cm H2O after 72 hours. Mean ventilatory time support was 131 hours and mean total oxygen dependency 10 days. No systemic hypotension nor any other adverse effect were noted. All infants survived and the neurodevelopmental assessment was normal at 6 and 12 months of age. It is concluded that magnesium sulphate is a non-aggressive and low-cost treatment of short duration which is easy to apply. It may have a role in the various treatment of PPHN.<\/jats:p>","DOI":"10.1136\/fn.72.3.f184","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T17:55:51Z","timestamp":1225475751000},"page":"F184-F187","source":"Crossref","is-referenced-by-count":44,"title":["Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn."],"prefix":"10.1136","volume":"72","author":[{"given":"J. F.","family":"Tolsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cotting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sekarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Payot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Calame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1995,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0022-3468(84)80257-2","article-title":"Alveolar-arterial oxygen gradients versus the neonatal pulmonary insufficiency index for prediction of mortality in ECMO candidates","volume":"19","author":"Krummel, T.M.; Lazar, J.; Greenfield, B.V.; Kirkpatrick, D.G.; Mueller, K.W.; Kerkering, M.O.","year":"1984","unstructured":"Krummel TM, Lazar J, Greenfield BV, Kirkpatrick DG, Mueller KW, Kerkering MO, et al. Alveolar-arterial oxygen gradients versus the neonatal pulmonary insufficiency index for prediction of mortality in ECMO candidates. J Pediatr Surg 1984; 19: 380-4.","journal-title":"J Pediatr Surg"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0031-3955(16)36179-X","article-title":"Extracorporeal membrane oxygenation in pediatric respiratory failure","volume":"34","author":"Ortiz, R.M.; Cilley, R.E.; Bartlett, R.H.","year":"1987","unstructured":"Ortiz RM, Cilley RE, Bartlett RH. Extracorporeal membrane oxygenation in pediatric respiratory failure. Pediatr Clin North Am 1987; 34: 39-46.","journal-title":"Pediatr Clin North Am"},{"key":"ref_3","first-page":"617","article-title":"Neonatal hypoxia and pulmonary vasospasm: response to tolazoline","volume":"89","author":"Goetzmann, B.W.; Sunshine, P.; Johnson, J.D.; Wennberg, R.P.; Hackel, A.; Merten, D.F.","year":"1976","unstructured":"Goetzmann BW, Sunshine P, Johnson JD, Wennberg RP, Hackel A, Merten DF, et al. Neonatal hypoxia and pulmonary vasospasm: response to tolazoline. J7 Pediatr 1976; 89: 617-21."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0022-3476(85)80200-6","article-title":"Prostacyclin in the treatment of neonatal pulmonary hypertension","volume":"107","year":"1985","unstructured":"Kapaa P, Koivisto M, Ylikorkala 0, Kouvalainen K. Prostacyclin in the treatment of neonatal pulmonary hypertension.JPediatr 1985; 107: 951-3.","journal-title":"JPediatr"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1542\/peds.76.4.479","article-title":"Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study","volume":"76","author":"Bartlett, R.H.; Roloff, D.W.; Cornel, R.G.; Andrews, A.F.; Dillon, P.W.; Zwischenberger, J.B.","year":"1985","unstructured":"Bartlett RH, Roloff DW, Cornel RG, Andrews AF, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics 1985; 76: 479-87.","journal-title":"Pediatrics"},{"key":"ref_6","first-page":"563","article-title":"Extracorporeal membrane oxygenation and neonatal respiratory failure: Experience from the extracorporeal life support organization. J7 Pediatr Surg","volume":"26","author":"Stolar, C.J.H.; Snedecor, S.M.; Bartlett, R.H.","year":"1991","unstructured":"Stolar CJH, Snedecor SM, Bartlett RH. Extracorporeal membrane oxygenation and neonatal respiratory failure: Experience from the extracorporeal life support organization. J7 Pediatr Surg 1991; 26: 563-7 1."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0140-6736(92)92686-A","article-title":"Inhaled nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"Roberts, J.D.; Polaner, D.M.; Lang, P.; Zapol, W.M.","year":"1992","unstructured":"Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-9.","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-3476(05)81551-3","article-title":"Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide","volume":"123","author":"Kinsella, J.P.; Neish, SR, Ivy; DD, Shaffer; E, Abman; S.H.","year":"1993","unstructured":"Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. Jf Pediatr 1993; 123: 103-8.","journal-title":"Jf Pediatr"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1542\/peds.92.4.606","article-title":"Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension","volume":"92","author":"Abman, S.H.; Kinsella, J.P.; Schaffer, M.S.; Wilkening, R.B.","year":"1993","unstructured":"Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 1993; 92: 606-9.","journal-title":"Pediatrics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/fn.70.1.F47","article-title":"Guidelines for the safe administration of inhaled nitric oxide","volume":"70","author":"Miller, O.I.; Celermajer, D.S.; Deanfield, J.E.; Macrae, D.J.","year":"1994","unstructured":"Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 1994; 70: F47-9.","journal-title":"Arch Dis Child"},{"key":"ref_11","first-page":"2672","article-title":"Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases","volume":"40","author":"Altura, B.M.; Altura, B.T.","year":"1981","unstructured":"Altura BM, Altura BT. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. FASEB J 1981; 40: 2672-9.","journal-title":"FASEB J"},{"key":"ref_12","first-page":"453","article-title":"Influence of high-dose IV MgSO4 therapy in pregnancy on mother and child Clinical and laboratory findings","volume-title":"A relevant ion","author":"Wischnik, A.; Hiltmann, W.D.; Hettenbach, A.; Schmidt, R.; Zieger, W.; Neises, M.","year":"1990","unstructured":"Wischnik A, Hiltmann WD, Hettenbach A, Schmidt R, Zieger W, Neises M, et al. Influence of high-dose IV MgSO4 therapy in pregnancy on mother and child Clinical and laboratory findings. In: Lasserre B, Durlach J, eds. Magnesium - A relevant ion. London: John Libbey & Co, 1990: 453-64."},{"key":"ref_13","first-page":"574","article-title":"Effect of maternally administered magnesium sulfate on the neonate","volume":"35","author":"Stone, SR, Pritchard; J.A.","year":"1970","unstructured":"Stone SR, Pritchard JA. Effect of maternally administered magnesium sulfate on the neonate. Obstet Gynecol 1970; 35: 574-7.","journal-title":"Obstet Gynecol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1152\/jappl.1968.24.6.755","article-title":"Reduction of hypoxic pulmonary vasoconstriction by magnesium chloride","volume":"24","author":"Cropp, G.J.A.","year":"1968","unstructured":"Cropp GJA. Reduction of hypoxic pulmonary vasoconstriction by magnesium chloride. Jf Appl Physiol 1968; 24: 755-60.","journal-title":"Jf Appl Physiol"},{"key":"ref_15","first-page":"110","article-title":"Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment","volume":"8","author":"Mathew, R.; Altura, B.T.; Altura, B.M.","year":"1989","unstructured":"Mathew R, Altura BT, Altura BM. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment. Magnesium 1989; 8: 110-6.","journal-title":"Magnesium"},{"key":"ref_16","first-page":"31","article-title":"Reduction of hypoxia-induced pulmonary hypertension (HIPH) by MgSO4 in sheep. Pediatr Res 1990; 27: 351A. 17 Abu-Osba","volume":"67","author":"A. A.","year":"1992","unstructured":"Abu-Osba YK, Rhydderch D, Balasundaram S, Galal 0, Rejjal A, Halees Z, et al. Reduction of hypoxia-induced pulmonary hypertension (HIPH) by MgSO4 in sheep. Pediatr Res 1990; 27: 351A. 17 Abu-Osba YK, Manasra K, Galal 0, Rejjal A. Treatment of pulmonary hypertension of newborn (PPHN) with magnesium. Peditra Res 1990; 27: 294A. 18 Abu-Osba YK, Galal 0, Manasra K, Rejjal A. Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 1992; 67: 31-5.","journal-title":"Arch Dis Child; Treatment of pulmonary hypertension of newborn (PPHN) with magnesium. Peditra Res 1990; 27: 294A. 18 Abu-Osba YK"},{"key":"ref_17","first-page":"\"5A.\" # \"657","article-title":"Le sulfate de magnesium: une altemative dans le traitment de l'hypertension pulmonaire persistante de nouveau-ne?","volume":"123","author":"Tolsa, J.-F.; Cotting, J.; Sekarski, N.; Calame, A.","year":"1993","unstructured":"Tolsa J-F, Cotting J, Sekarski N, Calame A. Le sulfate de magnesium: une altemative dans le traitment de l'hypertension pulmonaire persistante de nouveau-ne? Schweiz Med Wochenschr 1993; 123: 5A. 20 Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70: 657-62.","journal-title":"Schweiz Med Wochenschr; Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation"},{"key":"ref_18","article-title":"Statistical methods","author":"Snedecor, G.W.; Cochran, W.G.","year":"1967","unstructured":"Snedecor GW, Cochran WG. Statistical methods. Ames, Iowa: Iowa State University Press, 1967."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00260875","article-title":"Regulation of the pulmonary circulation in the perinatal period and in children","volume":"15","author":"Heymann, M.A.","year":"1989","unstructured":"Heymann MA. Regulation of the pulmonary circulation in the perinatal period and in children. Intensive Care Med 1989; 15: S9-12.","journal-title":"Intensive Care Med"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0031-3955(16)38619-9","article-title":"Advances in the treatment of persistent pulmonary hypertension of the newborn","volume":"40","author":"Roberts, J.D.; Shaul, P.W.","year":"1993","unstructured":"Roberts JD, Shaul PW. Advances in the treatment of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am 1993; 40: 983-1004.","journal-title":"Pediatr Clin North Am"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-3782(93)90142-H","article-title":"Persistent pulmonary hypertension in the newbom","volume":"33","author":"Yu, V.I.H.","year":"1993","unstructured":"Yu VIH. Persistent pulmonary hypertension in the newbom. Early Hum Dev 1993; 33: 163-75.","journal-title":"Early Hum Dev"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1542\/peds.92.3.403","article-title":"Endotracheal administration of tolazoline in hypoxia-induced pulmonary hypertension","volume":"92","author":"Curtis, J.; O'Neill, T.; Pettett, G.","year":"1993","unstructured":"Curtis J, O'Neill T, Pettett G. Endotracheal administration of tolazoline in hypoxia-induced pulmonary hypertension. Pediatrics 1993; 92: 403-8.","journal-title":"Pediatrics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/fn.71.3.F214","article-title":"Aerosolised prostacyclin for pulmonary hypertension in neonates","volume":"71","author":"Bindl, L.; Fahnenstich, H.; Peukert, U.","year":"1994","unstructured":"Bindl L, Fahnenstich H, Peukert U. Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child 1994; 71: F214-6.","journal-title":"Arch Dis Child"},{"key":"ref_24","first-page":"650","article-title":"Hearing loss in infants with persistent fetal circulation","volume":"81","author":"Hendricks-Munoz, K.D.; Walton, J.P.","year":"1988","unstructured":"Hendricks-Munoz KD, Walton JP. Hearing loss in infants with persistent fetal circulation. Pediatics 1988; 81: 650-6.","journal-title":"Pediatics"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fn.72.3.F184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T10:42:29Z","timestamp":1757068949000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/fn.72.3.F184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1995,5,1]]},"published-print":{"date-parts":[[1995,5]]}},"alternative-id":["10.1136\/fn.72.3.F184"],"URL":"https:\/\/doi.org\/10.1136\/fn.72.3.f184","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}